|
RAD51L3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.50200000004608E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
5.060500E-02 |
| Stage1-vs-Stage3 |
2.028400E-01 |
| Stage1-vs-Stage4 |
5.657900E-03 |
| Stage2-vs-Stage3 |
8.880700E-03 |
| Stage2-vs-Stage4 |
1.763950E-04 |
| Stage3-vs-Stage4 |
8.943700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.79820000293319E-09 |
| Normal-vs-Asian |
1.69053659959673E-12 |
| Caucasian-vs-AfricanAmerican |
8.544400E-01 |
| Caucasian-vs-Asian |
9.429600E-01 |
| AfricanAmerican-vs-Asian |
8.266200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
5.167800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(81-100Yrs) |
4.62800000000652E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.402400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.649800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.895000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.120800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.949200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.605600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.3362999999943E-05 |
| Classical-VS-Follicular |
2.535400E-03 |
| Classical-VS-Other |
2.958000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.99969999950633E-08 |
| Tall-VS-Other |
6.937400E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
8.105900E-02 |
| Follicular-VS-Normal |
6.72309999893983E-08 |
| Other-VS-Normal |
1.6176999999562E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
5.55111512312578E-16 |
| N0-vs-N1 |
1.196580E-03 |
|
|
